FIELD: medicine.
SUBSTANCE: invention relates to medicine, and concerns a method for predicting the efficacy of monotherapy with oral antidiabetic drug metformin in patients with type 2 diabetes. Method consists in the fact that in patients with type 2 diabetes DNA is extracted from peripheral venous blood, followed by polymerase chain reaction (PCR) and conducting analysis to detect polymorphism A>C rs 622342 of OST1 gene. When identifying genotype AA in the area rs 622342 of OST1 gene predict the effectiveness of monotherapy with metformin as antidiabetic drug in patients with type 2 diabetes, and when identifying genotype AC and CC in the area rs 622342 of OST1 gene predict the ineffectiveness of monotherapy with metformin as antidiabetic drug in this group of patients.
EFFECT: use of the method allows to increase the accuracy and specificity of predicting the effectiveness of monotherapy of oral antihyperglycemic drug metformin in patients with type 2 diabetes.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD PREDICTION OF THERAPY EFFECIENCY FOR PATIENTS WITH TYPE 2 SUGAR DIABETES | 2015 |
|
RU2626670C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE AND TREATMENT EFFICACY OF TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533286C1 |
| METHOD OF TREATING PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2009 |
|
RU2398572C1 |
| METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2 | 2013 |
|
RU2533456C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF SEVERE COURSE OF DISTAL NEUROPATHY AND DIABETIC FOOT SYNDROME IN PATIENTS WITH TYPE 1 AND 2 DIABETES MELLITUS | 2022 |
|
RU2799032C1 |
| METHOD OF EARLY GENETIC DIAGNOSTICS OF RISK FOR DEVELOPING TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2655635C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN MALES BASED ON GENOTYPING POLYMORPHISM rs3219484 (C>T) OF MUTYH GENE | 2024 |
|
RU2837004C1 |
| METHOD FOR PREDICTION OF RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN WITH OBESITY BASED ON GENOTYPING rs469994 (G>A) ZNRF3 GENE POLYMORPHISM | 2024 |
|
RU2841195C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs755892 POLYMORPHISM OF THE DNAJB1 GENE | 2023 |
|
RU2803637C1 |
| METHOD FOR SELECTION OF HYPOGLYCEMIC THERAPY FOR PATIENTS WITH DIABETES MELLITUS IN OUTCOME OF EXOCRINE PANCREAS DISEASES | 2024 |
|
RU2839905C1 |
